Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2000
Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages
Y Pommier, G Kohlhagen, P Pourquier, et al.
Anti-Cancer Drugs
|
February 1, 1995
Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line
C Massart, J Gibassier, M Raoul, et al.
European Journal of Biochemistry
|
April 15, 1997
Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells
D Montaudon, P Pourquier, F Denois, et al.
Leukemia
|
October 1, 1995
Effect of 5637-conditioned medium and recombinant cytokines on P-glycoprotein expression in a human GM-CSF-dependent leukemic myeloid cell line
J D Bailly, P Pourquier, J P Jaffrézou, et al.
The Journal of Biological Chemistry
|
March 21, 1997
Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I
P Pourquier, L M Ueng, G Kohlhagen, et al.
Cancer Research
|
February 24, 2001
Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine
P Pourquier, J L Waltman, Y Urasaki, et al.
Molecular Pharmacology
|
August 27, 1999
DNA protein cross-links produced by NSC 652287, a novel thiophene derivative active against human renal cancer cells
W Nieves-Neira, M I Rivera, G Kohlhagen, et al.
British Journal of Cancer
|
January 21, 2015
BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
A Laroche-Clary, V Chaire, V Le Morvan, et al.
The Journal of Biological Chemistry
|
March 20, 1999
Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine
P Pourquier, L M Ueng, J Fertala, et al.
Cancer Research
|
March 31, 2001
Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line
Y Urasaki, G S Laco, P Pourquier, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2000
Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages
Y Pommier, G Kohlhagen, P Pourquier, et al.
Anti-Cancer Drugs
|
February 1, 1995
Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line
C Massart, J Gibassier, M Raoul, et al.
European Journal of Biochemistry
|
April 15, 1997
Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells
D Montaudon, P Pourquier, F Denois, et al.
Leukemia
|
October 1, 1995
Effect of 5637-conditioned medium and recombinant cytokines on P-glycoprotein expression in a human GM-CSF-dependent leukemic myeloid cell line
J D Bailly, P Pourquier, J P Jaffrézou, et al.
The Journal of Biological Chemistry
|
March 21, 1997
Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I
P Pourquier, L M Ueng, G Kohlhagen, et al.
Cancer Research
|
February 24, 2001
Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine
P Pourquier, J L Waltman, Y Urasaki, et al.
Molecular Pharmacology
|
August 27, 1999
DNA protein cross-links produced by NSC 652287, a novel thiophene derivative active against human renal cancer cells
W Nieves-Neira, M I Rivera, G Kohlhagen, et al.
British Journal of Cancer
|
January 21, 2015
BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
A Laroche-Clary, V Chaire, V Le Morvan, et al.
The Journal of Biological Chemistry
|
March 20, 1999
Induction of reversible complexes between eukaryotic DNA topoisomerase I and DNA-containing oxidative base damages. 7, 8-dihydro-8-oxoguanine and 5-hydroxycytosine
P Pourquier, L M Ueng, J Fertala, et al.
Cancer Research
|
March 31, 2001
Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line
Y Urasaki, G S Laco, P Pourquier, et al.
Page
of 4